Indication

Homocystinuria

Homocystinuria is a rare, inherited inborn error of amino acid metabolism most commonly caused by an autosomal recessive deficiency in cystathionine beta-synthase (CBS), or less frequently by defects in cobalamin or folate remethylation pathways. Read more about Homocystinuria

4 drugs 4 manufacturers

Advertisement

Drugs that treat it

Common Homocystinuria therapies.

Showing 1–4 of 4 drugs

Filter & compare in the drug finder →Opens the drug finder with Homocystinuria preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Homocystinuria.

Homocystinuria is a rare, inherited inborn error of amino acid metabolism most commonly caused by an autosomal recessive deficiency in cystathionine beta-synthase (CBS), or less frequently by defects in cobalamin or folate remethylation pathways.

This defect impairs the transsulfuration or remethylation of homocysteine, leading to the toxic systemic accumulation of homocysteine and its metabolic precursors, such as methionine, in the blood and urine.

The disease affects multiple organ systems, with clinical manifestations typically presenting in infancy or childhood.

Pathognomonic and defining features include ectopia lentis (lens dislocation) and severe myopia, skeletal abnormalities resembling Marfan syndrome (such as tall stature, scoliosis, and early-onset osteoporosis), developmental delay or intellectual disability, and an elevated lifelong risk of life-threatening arterial and venous thromboembolism.

Personalize your experience

Follow Homocystinuria and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it